Daniela Dimarco, MD

Articles by Daniela Dimarco, MD

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

ByAndrew J. Hale, MD,Daniela Dimarco, MD,John W. Ahern, PharmD*

May 29th 2019

This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.

Partial Oral Treatment of Infective Endocarditis Can Be Effective in Select Patients: Review of the POET Trial

ByAndrew J. Hale, MD,Daniela Dimarco, MD

September 20th 2018

By itself, the POET trial should not fundamentally change the current approach to infective endocarditis treatment.

Latest Updated Articles

Partial Oral Treatment of Infective Endocarditis Can Be Effective in Select Patients: Review of the POET Trial
September 20th 2018
Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC
May 29th 2019

Daniela Dimarco, MD

Articles by Daniela Dimarco, MD

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

Partial Oral Treatment of Infective Endocarditis Can Be Effective in Select Patients: Review of the POET Trial

Latest Updated Articles

Trending on Contagion Live

Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311

ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections

The HIV Testing Gap and What Clinicians Can Do About It

When Fever in Infants is Invasive Bacterial Infection

Once-Weekly HIV Pill Meets Phase 3 Endpoints, Advancing Potential First Long-Acting Oral Treatment